ORCHID PHARMA
Back to Cashflow Statement
|
ORCHID PHARMA Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹18 Cr | ₹-19 Cr | ₹18 Cr | ₹-11 Cr | ₹-74 Cr |
What is the latest Net Cash Inflow / Outflow ratio of ORCHID PHARMA ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹18 Cr |
| Mar2024 | ₹-19 Cr |
| Mar2023 | ₹18 Cr |
| Mar2022 | ₹-11 Cr |
| Mar2021 | ₹-74 Cr |
How is Net Cash Inflow / Outflow of ORCHID PHARMA Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹18 Cr | Positive | |
| Mar2024 | ₹-19 Cr | Negative | |
| Mar2023 | ₹18 Cr | Positive | |
| Mar2022 | ₹-11 Cr | Negative | |
| Mar2021 | ₹-74 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of ORCHID PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ORCHID PHARMA | ₹3,497.3 Cr | -2.3% | -10.6% | -57.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹391,488.0 Cr | -2.1% | -7.7% | -9.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,415.0 Cr | -2.6% | -6.8% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹132,906.0 Cr | 0.1% | 5.5% | 25.3% | Stock Analytics | |
| CIPLA | ₹106,210.0 Cr | -1.9% | -9.3% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,089.0 Cr | 3.5% | -5.2% | -11.8% | Stock Analytics | |
ORCHID PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ORCHID PHARMA | -2.3% |
-10.6% |
-57.1% |
| SENSEX | -2.4% |
-4.7% |
6.4% |
You may also like the below Video Courses